INBRIJA 33 MG POLVO PARA INHALACION CAPSULAS DURAS

Acorda Therapeutics Ireland Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 36b65c7506c173dc
Drug Cima Aemps Name: INBRIJA 33 MG POLVO PARA INHALACION CAPSULAS DURAS
Register Number: 1191390002
Holder Company Name: Acorda Therapeutics Ireland Limited
Marketing Company Name: Esteve Pharmaceuticals S.A.
Holder Company Detail Path: /organization/acorda-therapeutics-ireland-limited
Marketing Company Detail Path: /organization/esteve-pharmaceuticals-s-a
Authorization Date: 2021-12-21
Dosage Form: POLVO PARA INHALACIÓN (CÁPSULA DURA)
Dose: 33 mg
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Acorda Therapeutics Ireland Limited
Company Detail Path: /organization/acorda-therapeutics-ireland-limited

LEVODOPA

33 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 21, 2021

Approval ID

36b65c7506c173dc

Type

Standard